Related Experiment Videos
Complement activation and inhibition in experimental models of arthritis
1Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff, UK. lintonsm@cf.ac.uk
Molecular Immunology
|March 4, 2000
Summary
Complement activation plays a role in rheumatoid arthritis (RA). Inhibiting complement locally in experimental arthritis models shows promise for treating human inflammatory arthritis.
Area of Science:
- Immunology and Rheumatology: Focus on complement system's role in inflammatory and autoimmune diseases.
Background:
- Complement activation is a key pathological mechanism in chronic inflammatory and autoimmune disorders like rheumatoid arthritis (RA).
- Experimental arthritis models are crucial for understanding RA pathogenesis and developing new therapies, with many models relying on complement activity.
Purpose of the Study:
- To investigate the therapeutic potential of complement inhibition in experimental arthritis models.
- To explore targeted complement inhibition strategies for inflammatory arthritis.
Main Methods:
- Utilizing various experimental arthritis models that are dependent on complement activation.
- Employing naturally occurring complement regulatory proteins and novel engineering strategies for targeted complement inhibition.
Main Results:
- Complement inhibition, particularly local inhibition, significantly influenced the incidence and progression of disease in experimental models.
- Targeted complement inhibition strategies demonstrated improved efficiency and therapeutic benefit.
Conclusions:
- Successful complement inhibition in experimental arthritis models suggests a novel therapeutic avenue for human inflammatory arthritis.
- Targeted and locally applied complement inhibition offers a promising approach for managing inflammatory arthritis.